eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 
eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 

Your Online Guide » Weight Loss » best diet to lose weight

[T520]The Hollywood Miracle Diet
by Nick Johnson, Nic
The reason for such a large consumption was the immediate weight loss associated with the drug. However, after ties between Fen Phen and the fatal Primary Pulmonary Hypertension were established, American Home Products removed the drug from the market in mid September of ’97. While Fen Phen supporters did not want to believe the horrible side effects that would befall some, they soon came to the realization that the drug was quite harmful. Soon after Fen Phen was pulled from American shelves, evidence implicating AHP of withholding serious knowledge of the harmful side effects the drug would cause came to light. Since millions of people had taken the diet drug Fen Phen, a large percentage of these people were experiencing drastic side effects, and in some cases even death. Many people say they would pay any price to lose weight. However, death was not the price they wanted to pay. A large number of the lawsuits filed in state court were filed because of the different effects Fen Phen caused on people’s health. The people filing suit were seeking some type of compensation for the rising medical bills they were incurring. In late 1997, every single federal Fen Phen case was transferred to the United States District Court. This event started a series of nationwide Fen Phen settlements. In mid-November of 99, preliminary approval was given to the settlement class. In order to find that the agreement reached in the settlement was fair, the district court held a hearing. In August of 2000, the settlement agreement was awarded approval. Thus creating the American Home Products Settlement Trust. After attempts to overturn the court’s ruling, the AHP gave in to the settlement. If you are a patient who has suffered from PPH (Primary Pulmonary Hypertension) caused by the diet drug Fen Phen, then you should know that you are not part of the settlement agreement with AHP. All Primary Pulmonary Hypertension patients are required to file independent lawsuits to make any legal claim.

Good health is a blessing which is more valuable than millions of dollars. Once health starts deteriorating even a millionaire can become a beggar. Planned and proper life style ipso-facto keeps away from many diseases. Improper and unplanned life style is an invitation for many dangerous diseases like obesity to come into your life. Calling obesity and diseases related with it "a herd of life snatching beasts" is not an exaggeration. Fatal diseases like cardio-vascular trouble, arthritis, brain stroke and many more can be resultant of obesity [acomplia online].Denmark can be third country for opening its direct sale. Sanofi-Aventis is planning to open sale of Acomplia in all major European countries with in next nine months. FDA approval for Acomplia is still awaited but the drug company is expecting it very soon. Only after that it will be available in the American drug market.Doctor's prescription for taking Acomplia is necessary. The doctor can suggest 20mg pill of Acomplia everyday before breakfast. Breast feeding mothers, obese women who are planning to have a child soon, patient of hepatic and renal diseases are prohibited from consuming Acomplia. Due to non-adaptation of the body with the drug can give some initial and mild problems like dizziness, gastro-intestine disorder, irritation, dry mouth etc. These complications are short lived generally disappear within few days [buy acomplia].
Acomplia can enable you to be a king of your will, and obesity will no longer stop you from doing those great things. Play football, go on ride, drive bike, participate in dance programs which means simply live life like a king.While the obesity market is potentially huge, antiobesity drugs have historically failed to sell, particularly in the US. The key factor behind this muted market response is likely to be the difficulty in securing reimbursement from the healthcare insurers. One way for pharmaceutical companies to tackle this issue is to shift this drug class away from the 'lifestyle' category and to 'medicalize' obesity. Lehman Brothers is forecasting the new antiobesity agents to erode generic phentermine market share from 2006 onwards, pushing the global market value from $US330 million in 2003 to around $US2 billion in 2010.The pipeline for antiobesity drugs is very active, with many companies on the verge of capitalizing on the increasing 'medicalization' of obesity begun by Roche and Abbott. Much of the development is taking place in the US.Acomplia (rimonabant) is currently in phase III development with Sanofi-Synthelabo. It is the first in a new class of drugs called selective cannabinoid CB1 receptor antagonists (CB1 blockers) and will be the next drug to enter the weight-loss market. The endocannabinoid system is believed to play a role in maintaining energy balance through the regulation of food intake and energy expenditure, although the exact mechanism of the pathway is not yet fully understood [acomplia online]. By selectively blocking the CB1 receptor, it is hoped that Acomplia will help normalize the body's energy equilibrium.Sanofi is conducting four phase III studies evaluating the weight-loss effects of Acomplia, two of which focus on the metabolic effects of the drug. By focusing on metabolic parameters in the RIO-Lipids and RIO-Diabetes trials, Sanofi is aiming to 'medicalize' obesity in order to convince healthcare payers that the benefits of Acomplia extend beyond weight loss, thus distinguishing this product from the 'lifestyle drug' label.If you want to learn more click here

Article Source : Diet Programs

About Author
Both Nick Johnson & john lenny are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.

Nick Johnson has sinced written about articles on various topics from Obesity, Health and Class Action. Nick Johnson is a personal injury attorney and lead counsel with Johnson Law Group, a personal injury law firm with principal offices located in Houston, Texas. Mr. Johnson represents injured people in injury cases and matters involving Fen-Phen and Pr. Nick Johnson's top article generates over 27100 views. to your Favourites.

john lenny has sinced written about articles on various topics from Dieting. Acomplia diet pill is the true solution for drive your obesity towards slimness and smart body shape.. john lenny's top article generates over 590 views. to your Favourites.
EditorialToday Weight Loss has 4 sub sections. Such as Types of Diet, Weight Loss, Weight Loss Surgery and Weight Loss Pills. With over 20,000 authors and writers, we are a well known online resource and editorial services site in United Kingdom, Canada & America . Here, we cover all the major topics from self help guide to A Guide to Business, Guide to Finance, Ideas for Marketing, Legal Guide, Lettre De Motivation, Guide to Insurance, Guide to Health, Guide to Medical, Military Service, Guide to Women, Pet Guide, Politics and Policy , Guide to Technology, The Travel Guide, Information on Cars, Entertainment Guide, Family Guide to, Hobbies and Interests, Quality Home Improvement, Arts & Humanities and many more.
About Editorial Today | Contact Us | Terms of Use | Submit an Article | Our Authors